An authorized generic of Aggrastat was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (tirofiban hydrochloride) is available.
Source: FDA, updated October 30, 2026
Generic name: tirofiban
Used for: Lowering heart attack risk in acute coronary syndrome
Ask for the cash price
Generic tirofiban
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as Aggrastat, and the FDA requires it to work the same way.
Details for each option
We didn’t find a savings card or cash price from Aggrastat’s maker. Ask the pharmacy for Aggrastat’s cash price. With insurance, ask what your plan charges.
An authorized generic of Aggrastat was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (tirofiban hydrochloride) is available.
Source: FDA, updated October 30, 2026
3 companies sell a generic of Aggrastat that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.
5 mg/100 mL
| Package | NDC |
|---|---|
| Carton of 100 mL | 55150-429-01 |
12.5 mg/250 mL
| Package | NDC |
|---|---|
| Carton of 250 mL | 55150-430-01 |
Inactive ingredients: anhydrous citric acid, trisodium citrate dihydrate, sodium chloride, water
50 mcg/mL
| Package | NDC |
|---|---|
| Carton of 250 mL | 14789-102-02 |
| Carton of 500 mL | 14789-102-10 |
Inactive ingredients: trisodium citrate dihydrate, sodium chloride, citric acid monohydrate
Made by Gland Pharma
Product page on sagentpharma.com
50 mcg/mL
| Package | NDC |
|---|---|
| Carton of 250 mL | 25021-417-84 |
Inactive ingredients: sodium chloride, trisodium citrate dihydrate, anhydrous citric acid, water, sodium hydroxide, hydrochloric acid
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
AGGRASTAT is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Source: the FDA label for Aggrastat (Medicure International Inc), January 1, 2025. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/aggrastat/